NASDAQ: AEGR
Price:
62.13
Change:
- 1.57
Day High:
64.36
Day Low:
62.04
Volume:
353,200
4:02 PM ET on Jun 19, 2013
Delayed at least 20 minutes.
Provided by eSignal.

Press Releases


All 2013 Releases
View Summary Aegerion Pharmaceuticals Grants Stock Options Under Inducement Program
Jun 6, 2013
PDF 10.0 KB Add to Briefcase
View Summary Aegerion Pharmaceuticals Receives Positive European CHMP Opinion for LOJUXTA(TM) (lomitapide) to Treat Homozygous Familial Hypercholesterolemia (HoFH)
May 31, 2013
PDF 13.4 KB Add to Briefcase
View Summary Aegerion Pharmaceuticals Announces Webcast of Investor Presentations at Upcoming Conferences
May 24, 2013
PDF 9.9 KB Add to Briefcase
View Summary Aegerion Pharmaceuticals Grants Stock Options Under Inducement Program
May 3, 2013
PDF 10.0 KB Add to Briefcase
View Summary Aegerion Pharmaceuticals Announces Presentation at the Bank of America Merrill Lynch 2013 Healthcare Conference
May 3, 2013
PDF 9.7 KB Add to Briefcase
View Summary Aegerion Pharmaceuticals Announces First-Quarter 2013 Financial Results
Apr 30, 2013
PDF 19.9 KB Add to Briefcase
View Summary Anne VanLent Appointed to Aegerion Pharmaceuticals' Board of Directors
Apr 29, 2013
PDF 10.4 KB Add to Briefcase
View Summary Aegerion Pharmaceuticals Announces Presentation at the Needham Healthcare Conference
Apr 25, 2013
PDF 9.8 KB Add to Briefcase
View Summary Aegerion Pharmaceuticals to Announce First Quarter 2013 Financial Results on Tuesday, April 30
Apr 16, 2013
PDF 9.9 KB Add to Briefcase
View Summary Aegerion Pharmaceuticals Grants Stock Options Under Inducement Program
Apr 3, 2013
PDF 9.9 KB Add to Briefcase
View Summary Aegerion Pharmaceuticals Announces Fourth-Quarter and Year-End 2012 Financial Results
Mar 6, 2013
PDF 76.3 KB Add to Briefcase
View Summary Aegerion Pharmaceuticals Grants Stock Options Under Inducement Program
Mar 5, 2013
PDF 10.4 KB Add to Briefcase
View Summary Aegerion Pharmaceuticals Observes Rare Disease Day
Feb 28, 2013
PDF 10.7 KB Add to Briefcase
View Summary Aegerion Pharmaceuticals Announces Presentation at the Cowen and Company 33rd Annual Health Care Conference
Feb 27, 2013
PDF 10.1 KB Add to Briefcase
View Summary Aegerion Pharmaceuticals to Announce Fourth Quarter 2012 Financial Results on Wednesday, March 6
Feb 20, 2013
PDF 10.4 KB Add to Briefcase
View Summary Aegerion Pharmaceuticals Announces Webcast of Investor Presentations at Upcoming Conferences
Feb 7, 2013
PDF 10.3 KB Add to Briefcase
View Summary Aegerion Pharmaceuticals Grants Stock Options Under Inducement Program
Feb 7, 2013
PDF 10.4 KB Add to Briefcase
View Summary Aegerion Pharmaceuticals Prices Public Offering of Common Stock
Jan 11, 2013
PDF 13.5 KB Add to Briefcase
View Summary Aegerion Pharmaceuticals Announces Proposed Public Offering of Common Stock
Jan 10, 2013
PDF 11.8 KB Add to Briefcase
View Summary Aegerion Pharmaceuticals Announces Key Business and Financial Objectives for 2013 as the Company Prepares for U.S. Launch of JUXTAPID(TM) (lomitapide) Capsules
Jan 7, 2013
PDF 67.3 KB Add to Briefcase
Showing 1-20 of 22 Page: 1 2  Next 20
Add to Briefcase = add release to Briefcase